News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
662,788 Results
Type
Article (48314)
Company Profile (203)
Press Release (614242)
Multimedia
Podcasts (156)
Webinars (24)
Section
Business (180249)
Career Advice (2623)
Deals (32722)
Drug Delivery (157)
Drug Development (80739)
Employer Resources (152)
FDA (15644)
Job Trends (14197)
News (317300)
Policy (31840)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2702)
Academic (1)
Accelerated approval (47)
Adcomms (38)
Allergies (168)
Alliances (45918)
ALS (214)
Alzheimer's disease (1843)
Antibody-drug conjugate (ADC) (467)
Approvals (15956)
Artificial intelligence (687)
Autoimmune disease (292)
Automation (53)
Bankruptcy (340)
Best Places to Work (10890)
BIOSECURE Act (19)
Biosimilars (231)
Biotechnology (104)
Bladder cancer (184)
Brain cancer (73)
Breast cancer (739)
Cancer (5792)
Cardiovascular disease (498)
Career advice (2225)
Career pathing (48)
CAR-T (330)
CDC (64)
Celiac Disease (1)
Cell therapy (889)
Cervical cancer (40)
Clinical research (70120)
Collaboration (2004)
Company closure (7)
Compensation (973)
Complete response letters (97)
COVID-19 (2770)
CRISPR (106)
C-suite (1173)
Cystic fibrosis (143)
Data (7742)
Decentralized trials (3)
Denatured (37)
Depression (177)
Dermatology (82)
Diabetes (595)
Diagnostics (6510)
Digital health (46)
Diversity (11)
Diversity, equity & inclusion (40)
Drug discovery (320)
Drug pricing (235)
Drug shortages (38)
Duchenne muscular dystrophy (289)
Earnings (72072)
Editorial (73)
Employer branding (19)
Employer resources (141)
Events (99189)
Executive appointments (1129)
FDA (19220)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (33)
Funding (1618)
Gene editing (229)
Generative AI (63)
Gene therapy (764)
GLP-1 (1176)
Government (4845)
Grass and pollen (7)
Guidances (410)
Healthcare (17285)
HIV (83)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (325)
Immuno-oncology (96)
Indications (183)
Infectious disease (3112)
Inflammatory bowel disease (217)
Inflation Reduction Act (15)
Influenza (134)
Intellectual property (280)
Interviews (540)
IPO (14573)
IRA (57)
Job creations (3606)
Job search strategy (1796)
JPM (70)
Kidney cancer (22)
Labor market (85)
Layoffs (600)
Leadership (49)
Legal (7371)
Liver cancer (100)
Longevity (28)
Lung cancer (782)
Lymphoma (428)
Machine learning (56)
Management (55)
Manufacturing (1036)
MASH (205)
Medical device (11690)
Medtech (11791)
Mergers & acquisitions (19313)
Metabolic disorders (1614)
mRNA (211)
Multiple sclerosis (188)
NASH (24)
Neurodegenerative disease (436)
Neuropsychiatric disorders (122)
Neuroscience (3401)
Neurotech (1)
NextGen: Class of 2026 (6141)
Non-profit (4260)
Now hiring (72)
Obesity (788)
Opinion (345)
Ovarian cancer (220)
Pain (264)
Pancreatic cancer (294)
Parkinson's disease (365)
Partnered (34)
Patents (586)
Patient recruitment (671)
Peanut (56)
People (58922)
Pharmaceutical (77)
Pharmacy benefit managers (36)
Phase 1 (21689)
Phase 2 (30777)
Phase 3 (23311)
Pipeline (8503)
Policy (352)
Postmarket research (2588)
Preclinical (9012)
Press Release (62)
Prostate cancer (298)
Psychedelics (65)
Radiopharmaceuticals (311)
Rare diseases (1117)
Real estate (5440)
Recruiting (65)
Regulatory (25020)
Reports (38)
Research institute (2398)
Resumes & cover letters (390)
Rett syndrome (38)
RNA editing (22)
RSV (87)
Schizophrenia (189)
Series A (275)
Series B (199)
Service/supplier (11)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (175)
Sponsored (45)
Startups (3352)
State (2)
Stomach cancer (20)
Supply chain (126)
Tariffs (102)
The Weekly (116)
Vaccines (1113)
Venture capital (115)
Weight loss (542)
Women's health (103)
Worklife (23)
Date
Today (199)
Last 7 days (884)
Last 30 days (3438)
Last 365 days (28873)
2026 (11648)
2025 (28835)
2024 (33152)
2023 (37219)
2022 (48028)
2021 (51851)
2020 (50641)
2019 (43938)
2018 (33312)
2017 (30842)
2016 (29876)
2015 (34708)
2014 (27674)
2013 (23114)
2012 (24600)
2011 (25397)
2010 (22957)
Location
Africa (857)
Alabama (88)
Alaska (5)
Arizona (272)
Arkansas (15)
Asia (41951)
Australia (7693)
California (11693)
Canada (3615)
China (1353)
Colorado (535)
Connecticut (481)
Delaware (382)
Europe (91794)
Florida (1873)
Georgia (365)
Hawaii (2)
Idaho (54)
Illinois (1004)
India (91)
Indiana (547)
Iowa (20)
Japan (540)
Kansas (122)
Kentucky (48)
Louisiana (39)
Maine (61)
Maryland (1497)
Massachusetts (8420)
Michigan (326)
Minnesota (640)
Mississippi (6)
Missouri (138)
Montana (28)
Nebraska (27)
Nevada (137)
New Hampshire (82)
New Jersey (3358)
New Mexico (29)
New York (3197)
North Carolina (1579)
North Dakota (7)
Northern California (5819)
Ohio (355)
Oklahoma (18)
Oregon (41)
Pennsylvania (2441)
Puerto Rico (30)
Rhode Island (46)
South America (1175)
South Carolina (79)
South Dakota (2)
Southern California (4665)
Tennessee (194)
Texas (1946)
United States (42415)
Utah (372)
Vermont (1)
Virginia (318)
Washington D.C. (77)
Washington State (980)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
662,788 Results for "gc pharma formerly known as green cross".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GC Biopharma Presents New Data at CIS 2026 to Expand Analytical Understanding of IVIG Product Characteristics
May 11, 2026
·
9 min read
Press Releases
GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
April 6, 2026
·
3 min read
Press Releases
GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
May 4, 2026
·
8 min read
Press Releases
GC Biopharma Receives Marketing Authorization for Varicella Vaccine ‘BARYCELA Inj.’ in Guatemala
March 26, 2026
·
3 min read
Press Releases
GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
April 17, 2026
·
8 min read
Press Releases
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, ‘MAV/06'
March 11, 2026
·
4 min read
C-suite
Lilly, J&J CEOs top pharma’s highest paid list—again
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.
May 13, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
GC Therapeutics Appoints Stem Cell Therapy Leader Stefan Irion, MD, as Chief Scientific Officer
May 5, 2026
·
6 min read
Press Releases
GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’
December 8, 2025
·
3 min read
Press Releases
2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
April 30, 2026
·
4 min read
1 of 66,279
Next
